| Abbreviation | Description |
| AD | Adenocarcinoma |
| ALDH | Aldehyde Dehydrogenase |
| B2M | Beta-2 Microglobulin |
| BPH | Benign Prostatic Hyperplasia |
| CD3 | Cluster of Differentiation 3 |
| CD4 | Cluster of Differentiation 4 |
| CD8 | Cluster of Differentiation 8 |
| CD19 | Cluster of Differentiation 19 |
| CD20 | Cluster of Differentiation 20 |
| CD25 | Cluster of Differentiation 25 |
| CD31 | Cluster of Differentiation 31 |
| CD34 | Cluster of Differentiation 34 |
| CD40 | Cluster of Differentiation 40 |
| CD44 | Cluster of Differentiation 44 |
| CD45 | Cluster of Differentiation 45 |
| CD56 | Cluster of Differentiation 56 |
| CD66b | Cluster of Differentiation 68 |
| CD68 | Cluster of Differentiation 68 |
| CD127 | Cluster of Differentiation 127 |
| cHL | Classical Hodgkin Lymphoma |
| C3aR | C3a receptor |
| CAF | Cancer-Associated Fibroblast |
| CK5 | Cytokeratin 5 |
| CK6 | Cytokeratin 6 |
| CK7 | Cytokeratin 7 |
| CK15 | Cytokeratin 15 |
| CODEX | CO-Detection by Indexing |
| CNN | Convolutional Neural Networks |
| cPLA2 | Cytosolic Phospholipase A2 |
| CRC | Colorectal Cancer |
| CRP1 | Cysteine Rich Protein 1 |
| CSF1R | Colony Stimulating Factor 1 Receptor |
| CTL | Cytotoxic T cells |
| cSCC | Cutaneous Squamous Cell Carcinoma |
| CytoMAP | Histo-Cytometric Multidimensional Analysis Pipeline |
| DB | Durable Benefit |
| DC | Dendritic Cell |
| DCIS | Ductal Carcinoma in Situ |
| DSP | Digital Spatial Analysis |
| Ebo | Burned-Out Effector |
| ECD | Extracellular Domain |
| EGFR | Epidermal Growth Factor Receptor |
| EpCAM | Epithelial Cell Adhesion Molecule |
| ER | Estrogen Receptor |
| ER-β | Estrogen Receptor Beta |
| ERK | Extracellular Signal-Regulated Kinase |
| ESCC | Esophageal Squamous Cell Carcinoma |
| FAP | Fibroblast Activation Protein |
| FF | Fresh Frozen |
| FFPE | Formalin-Fixed Paraffin-Embedded |
| FOXP3 | Forkhead Box P3 |
| G-cross | Cross-Type Nearest Neighbor Distance Distribution Function |
| γH2AX | Gamma H2A Histone Family Member X |
| HER2 | Human Epidermal Growth Factor Receptor 2 |
| HLA-DR | Human Leukocyte Antigen—DR isotype |
| HPV 16 | Human Papilloma Virus 16 |
| HRP | Horseradish Peroxidase |
| HSP27 | Heath Shock Protein 27 |
| ICD | Intracellular Domain |
| ICPI | Immune Checkpoint Inhibition |
| ICOS | Inducible T Cell Co-stimulation |
| IBC | Invasive Breast Cancer |
| IFNγ | Interferon Gamma |
| IMC | Imaging Mass Cytometry |
| IPT | Intraperitoneal Treatment |
| ITT | Intratumoral Treatment |
| KRAS | Kirsten Rat Sarcoma Viral Oncogene Homolog |
| LAG3 | Lymphocyte Activation Gene 3 |
| LC-MALDI-MS/MS | Liquid Chromatography-Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry |
| LTS | Long Term Survivors |
| MAPK | Mitogen-Activated Protein Kinase |
| MAPKAPK2 | Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 |
| MALDI-MSI | Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging |
| MEC | Myoepithelial E-Cadherin |
| mFOLFOX | modified Folinic Acid, Fluorouracil, and Oxaliplatin |
| MHC-I | Major Histocompatibility Complex I |
| MHC-II | Major Histocompatibility Complex II |
| MIBC | Muscle Invasive Bladder Cancer |
| MIBI-TOF | Multiplexed Ion Beam Imaging by Time-Of-Flight |
| MRI | Magnetic Resonance Imaging |
| nDB | Non-Durable Benefit |
| NDES | Nanofluidic Drug-Eluting Seed |
| NSCLC | Non-Small Cell Lung Cancer |
| OC | Ovarian Carcinoma |
| OSCC | Oral Squamous Cell Carcinoma |
| PD-1 | Programmed Cell Death Protein 1 |
| PD-L1 | Programmed Death-Ligand 1 |
| p-eIF4E | Phospho-Eukaryotic Translation Initiation Factor 4E |
| PGE2 | Prostaglandin E2 |
| POLE | DNA Polymerase Epsilon |
| p-p38 | Phospho-p38 |
| ROI | Region Of Interest |
| SBP1 | Selenium Binding Protein 1 |
| SCC | Squamous Cell Carcinoma |
| SIRT2 | Sirtuin 2 |
| STAT3 | Signal Transducer and Activator of Transcription 3 |
| SVCA | Spatial Variance Component Analysis |
| TAM | Tumor Associated Macrophages |
| TdT | Terminal Deoxynucleotidyl Transferase |
| Th | T Helper Cell |
| TIL | Tumor-Infiltrating Lymphocyte |
| TLS | Tertiary Lymphoid Structure |
| TME | Tumor Microenvironment |
| TNBC | Triple-Negative Breast Cancer |
| TNFα | Tumor Necrosis Factor Alpha |
| Treg | Regulatory T Cell |